Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
27.06
-1.29 (-4.53%)
At close: Mar 20, 2026, 4:00 PM EDT
26.63
-0.43 (-1.58%)
After-hours: Mar 20, 2026, 5:22 PM EDT
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $3.64 billion as of March 20, 2026. Its market cap has increased by 64.64% in one year.
Market Cap
3.64B
Enterprise Value
3.51B
1-Year Change
64.64%
Ranking
Category
Stock Price
$27.06
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $3.64B, an increase of 108.07%. That is a compound annual growth rate of 16.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.95B | 8.20% |
| Dec 31, 2025 | 3.65B | 65.43% |
| Dec 31, 2024 | 2.21B | 184.18% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
| May 28, 2021 | 1.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 4.20B |
| Viking Therapeutics | 3.92B |
| Crinetics Pharmaceuticals | 3.75B |
| Corcept Therapeutics | 3.63B |
| ADMA Biologics | 3.58B |
| Structure Therapeutics | 3.57B |
| Dianthus Therapeutics | 3.56B |
| ACADIA Pharmaceuticals | 3.53B |